Dana M. Zaher

Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells

Shifaa M. Abdin, Mai F. Tolba, Dana M. Zaher et al. · Chemico-Biological Interactions · 2021 · 74 citations

Medicine, Oncology, Pharmacology +12

Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities

Khaled R.A. Abdellatif, Wael A. A. Fadaly, Yaser A. Mostafa et al. · Bioorganic Chemistry · 2019 · 58 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells

Rawan M. Sbenati, Seyed–Omar Zaraei, Mohammed I. El–Gamal et al. · European Journal of Medicinal Chemistry · 2020 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Gliclazide attenuates acetic acid-induced colitis via the modulation of PPARγ, NF-κB and MAPK signaling pathways

El‐Shaimaa A. Arafa, Wafaa R. Mohamed, Dana M. Zaher et al. · Toxicology and Applied Pharmacology · 2020 · 31 citations

Medicine, Immunology, Pharmacology +12

Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase

Mohammed I. El–Gamal, Saif Ullah, Seyed–Omar Zaraei et al. · European Journal of Medicinal Chemistry · 2019 · 29 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12